METLIFE INC

LISTEDNYSE

SYMBOLMET

SIC6311

STATE OF INC.DE

FISCAL YEAR ENDSDecember 31

CIK1099219

LIFE INSURANCE · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures adjusted for later stock splits (split ratios inferred from EPS restated in later SEC filings).

CAPITALIZATION 12/31/25

($ millions)	Amount	%
Total debt	14,822	34.3
Stockholders' equity	28,398	65.7
Total capitalization	43,220	100.0

635,476,927 shares outstanding at 31 July 2026 (cover page of the 10-Q filed 6 August 2026).

LONG-TERM DEBT 12/31/25

($ millions)	Amount
Long-term debt, incl. current maturities	14,467
Short-term borrowings / commercial paper	355

CAPITAL STOCK 12/31/25

Common shares authorized	3,000,000,000
Common shares issued	1,195,587,190
Treasury shares	540,253,417
Par or stated value per share ($)	0.01
Preferred stock ($ millions)	0
Outstanding at 7/31/26	635,476,927

DIVIDENDS DECLARED/PAID

Fiscal year	Per share $	Payout %
2025	2.25	47.7
2024	2.15	36.3
2023	2.06	113.8
2022	1.98	31.4
2021	1.90	24.8

HISTORY AND BUSINESS

HISTORY: Incorporated in Delaware.

BUSINESS: Classified by the SEC under Standard Industrial Classification 6311, Life Insurance. Large accelerated filer. Principal executive office: 200 Park Avenue, New York, NY 10166. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)	12/31/25	12/31/24	12/31/23
Premiums earned	49,779	44,945	44,283
Net investment income	22,559	21,273	19,908
Total revenues	77,084	70,986	66,905
Benefits, losses and expenses	72,423	65,364	64,743
Income before income taxes	4,661	5,622	2,162
Income taxes	1,258	1,178	560
Net income	3,379	4,426	1,578
Earned per share, diluted ($)	4.71	5.94	1.81
Dividends per share ($)	2.25	2.15	2.06

CONSOLIDATED BALANCE SHEET

($ millions)	12/31/25	12/31/24
Total investments	472,178	441,364
Cash and equivalents	22,032	20,068
Total assets	745,166	677,457
Policy liabilities and reserves	208,855	193,646
Total liabilities	716,245	649,754
Stockholders' equity	28,398	27,445

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year ended	Revenues	Oper. income	Net income	Net margin %	EPS diluted $	Div. per share $	Oper. cash flow	Total assets	Total liabilities	Total debt	Deposits	Stockholders' equity	ROE %	Debt / equity
12/31/25	77,084	6,137	3,379	4.4	4.71	2.25	17,092	745,166	716,245	14,822	–	28,398	11.9	0.52
12/31/24	70,986	5,996	4,426	6.2	5.94	2.15	14,598	677,457	649,754	15,551	–	27,445	16.1	0.57
12/31/23	66,905	5,723	1,578	2.4	1.81	2.06	13,721	687,584	657,331	15,667	–	30,015	5.3	0.52
12/31/22	68,770	5,978	5,284	7.7	6.30	1.98	13,044	663,072	632,947	14,822	–	29,881	17.7	0.50
12/31/21	68,696	–	6,855	10.0	7.65	1.90	12,347	759,708	691,959	14,274	–	67,482	10.2	0.21
12/31/20	67,842	–	5,407	8.0	12.78	4.09	11,639	795,146	720,329	14,996	–	74,558	7.3	0.20
12/31/19	69,620	–	5,899	8.5	13.63	3.92	13,786	740,463	674,081	13,701	–	66,144	8.9	0.21
12/31/18	67,941	–	5,123	7.5	11.05	3.73	11,738	687,538	634,580	13,097	–	52,741	9.7	0.25
12/31/17	62,308	–	4,010	6.4	8.14	3.60	12,283	719,892	661,022	16,163	–	58,676	6.8	0.28
12/31/16	60,787	–	850	1.4	1.51	3.54	14,774	898,764	831,062	16,683	–	67,531	1.3	0.25

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; capital expenditure and free cash flow are not shown for banks and insurers, where they are not meaningful; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

METLIFE INC
CIK 1099219 · EIN 13-4075851

PRINCIPAL OFFICE:

200 Park Avenue, New York, NY 10166
Tel.: 212-578-5500

INCORPORATED:

Delaware

INDUSTRY (SEC SIC CODE):

6311 · Life Insurance

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 19 February 2026

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

9/24/26	8-K	period 9/24/26
8/17/26	8-K	period 8/17/26
8/6/26	10-Q	period 6/30/26
8/5/26	8-K	period 8/5/26
6/29/26	8-K	period 6/29/26
6/22/26	8-K	period 6/16/26
5/15/26	8-K	period 5/15/26
5/7/26	10-Q	period 3/31/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/19/26) · 10-K FY2024 (filed 2/21/25) · 10-K FY2023 (filed 2/16/24) · 10-K FY2022 (filed 2/23/23) · 10-K FY2021 (filed 2/18/22) · 10-K FY2020 (filed 2/19/21) · 10-K FY2019 (filed 2/21/20) · 10-K FY2018 (filed 2/22/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.